Daily Roundup

ALC.ASX GNP.ASX PME.ASX NHC.ASX GTK.ASX

Alcidion Group strengthens patient flow capabilities with Telstra Health acquisition

Alcidion Group has signed a deal to acquire Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ from Telstra Health. The acquisition will bolster Alcidion's position as a leading provider of enterprise patient flow solutions across Australia, New Zealand, and the UK, with particular expansion potential in Queensland and Victoria. The company is paying $3.0 million upfront, with an additional earn-out of up to $1.0 million based on future recurring revenue thresholds. The deal is expected to close by the end of June 2026 and should be earnings accretive from completion, with FY26 forecast revenue of $3.7 million and underlying EBITDA of approximately $1.1 million.

GenusPlus on a growth trajectory with upgraded guidance and major acquisition

GenusPlus Group is having quite the week. The infrastructure provider upgraded its FY2026 earnings guidance, now expecting normalized EBITDA between A$96 million and A$100 million—up from the previous A$91 million forecast. That's growth of around 42-48% compared to normalized FY2025 EBITDA of $67.4 million, with approximately A$2 million to A$3 million coming from the Railtrain Holdings acquisition completed in April.

But that's just the appetizer. GenusPlus also announced a transformational acquisition of MPC Kinetic Holdings for up to A$400 million, strategically diversifying the company into gas and water sectors. The deal is expected to be highly earnings accretive and will complement GenusPlus' existing electrical capabilities with MPK's pipeline and civil works expertise. MPC Kinetic's management team will stay on board, and the transaction is slated to complete on 1 July 2026, subject to GenusPlus completing an equity raise of at least A$200 million. The company now expects FY26F normalised EBITDA of A$195 million and normalised EBIT(A) of A$153 million. A trading halt has been requested pending the announcement of capital raising results, expected to lift by 20 May 2026.

Pro Medicus lands major US healthcare contract

Pro Medicus has signed a substantial 7-year, A$90 million contract with Boston-based Beth Israel Lahey Health. The deal covers implementation of the Visage 7 Enterprise Imaging Platform, including Visage 7 Viewer, Workflow, and Open Archive, all running on the cloud. The platform is targeted to go live in Q1 2027 and operates on a transactional licensing model with potential upside.

New Hope Corporation posts strong quarterly performance

New Hope Corporation delivered solid results for the quarter ended 30 April 2026. Group ROM coal production climbed 5.0% to 4.3 million tonnes, while coal sales jumped 10.4% to 3.2 million tonnes. The average realised sales price came in at $140.7 per tonne, slightly up from the previous quarter. Bengalla Mine achieved an impressive 12.4% reduction in FOB cash cost to $74.0 per sales tonne, while underlying EBITDA surged 21.7% to $130.1 million. The company finished the quarter with a healthy cash balance of $571.6 million. On the capital front, New Hope issued $300 million in new senior unsecured convertible notes due 2032 and repurchased $293.3 million principal amount of existing convertible notes due 2029. Looking ahead, the company expects increased demand as the Northern Hemisphere moves into summer, with the majority of production for the next three months already sold. FY26 guidance points to ROM coal production of 15,700 to 17,700 thousand tonnes and saleable coal production of 10,200 to 11,500 thousand tonnes.

Gentrack Group navigates mixed results while expanding through acquisitions

Gentrack Group's half-year results tell a story of strategic repositioning. Total revenue dipped 2% to $110.1 million, driven by a 30% drop in non-recurring project revenue and lower hardware sales. However, the company's recurring revenue—the real prize—climbed 12% to $85.3 million, with utilities recurring revenue up 9%. EBITDA excluding acquisition costs fell 39% to $7.9 million, and net profit after tax dropped 29% to $5.1 million, though a $3.9 million tax credit provided some relief. The company ended the period with a robust cash position of $73.2 million and no external debt.

Despite the near-term headwinds, Gentrack is making bold moves to drive future growth. The company acquired Prospero Energy Limited, which trades as Factor, a New Zealand-based SaaS business serving the energy retail sector. Factor's platform enables utilities to price and manage commercial electricity contracts at scale using machine learning. The enterprise value is NZ$24 million with a potential earn-out of NZ$10 million linked to growing Annual Recurring Revenues to approximately NZ$17 million within three years. The acquisition is funded from existing cash reserves and is expected to be accretive by FY28. This deal will enhance Gentrack's g2 energy retail platform and reinforce its leadership in the B2B energy retail segment.

Looking forward, Gentrack expects FY26 revenue between $229 million and $238 million with recurring revenues growing by more than 10%. The company remains confident in its medium-term growth target of more than 15% CAGR, with emphasis on building recurring revenue and improving EBITDA margins to 15-20%.